🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 05/09/2007 | 0,3626 USD |
| 06/06/2007 | 0,3626 USD |
| 07/03/2007 | 0,3626 USD |
| 06/12/2006 | 0,3626 USD |
| 30/08/2006 | 0,3626 USD |
| 31/05/2006 | 0,3626 USD |
| 08/03/2006 | 0,3626 USD |
| 30/11/2005 | 0,3626 USD |
| 31/08/2005 | 0,3626 USD |
| 01/06/2005 | 0,3626 USD |
| 02/03/2005 | 0,3626 USD |
| 01/12/2004 | 0,3626 USD |
| 01/09/2004 | 0,3626 USD |
| 02/06/2004 | 0,3531 USD |
| 03/03/2004 | 0,3531 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 13/05/2025 | 76,95 | 78,55 | 76,56 | 76,63 | -4,72% | 2,59% | 23.353.200 |
| 12/05/2025 | 75,92 | 81,27 | 75,83 | 80,43 | +5,87% | 7,17% | 21.761.100 |
| 09/05/2025 | 77,96 | 78,45 | 75,82 | 75,97 | -2,16% | 3,37% | 15.614.500 |
| 08/05/2025 | 78,50 | 78,80 | 76,93 | 77,65 | -1,86% | 2,38% | 15.059.100 |
| 07/05/2025 | 79,62 | 79,90 | 78,76 | 79,12 | +0,10% | 1,43% | 12.216.900 |
| 06/05/2025 | 82,47 | 82,48 | 78,29 | 79,04 | -4,59% | 5,08% | 16.991.100 |
| 05/05/2025 | 83,23 | 83,58 | 81,91 | 82,84 | -0,41% | 2,01% | 8.688.000 |
| 02/05/2025 | 84,19 | 84,71 | 82,95 | 83,18 | -0,10% | 2,09% | 11.755.600 |
| 01/05/2025 | 84,51 | 84,58 | 83,17 | 83,26 | -2,28% | 1,67% | 10.036.400 |
| 30/04/2025 | 85,27 | 85,83 | 83,79 | 85,20 | +0,58% | 2,39% | 13.825.100 |
| 29/04/2025 | 83,78 | 85,69 | 82,75 | 84,71 | +1,83% | 3,51% | 18.802.900 |
| 28/04/2025 | 83,00 | 83,68 | 82,40 | 83,19 | +0,54% | 1,54% | 14.241.000 |
| 25/04/2025 | 80,17 | 83,28 | 78,06 | 82,74 | +3,63% | 6,51% | 28.378.000 |
| 24/04/2025 | 78,28 | 79,97 | 76,03 | 79,84 | +1,40% | 5,03% | 18.471.500 |
| 23/04/2025 | 78,50 | 80,20 | 78,00 | 78,74 | -0,29% | 2,80% | 17.935.700 |
| 22/04/2025 | 78,03 | 79,04 | 77,66 | 78,97 | +1,44% | 1,77% | 12.918.200 |
| 21/04/2025 | 78,08 | 78,19 | 76,99 | 77,85 | -0,19% | 1,54% | 11.010.000 |
| 17/04/2025 | 76,89 | 78,75 | 76,88 | 78,00 | +2,01% | 2,43% | 21.416.500 |
| 16/04/2025 | 78,47 | 78,69 | 75,93 | 76,46 | -2,46% | 3,52% | 16.551.300 |
| 15/04/2025 | 79,55 | 79,96 | 77,72 | 78,39 | -0,99% | 2,82% | 16.042.500 |
| 14/04/2025 | 80,02 | 80,02 | 78,36 | 79,17 | -0,01% | 2,07% | 15.796.700 |
| 11/04/2025 | 77,87 | 79,44 | 76,35 | 79,18 | +2,10% | 3,97% | 16.194.400 |
| 10/04/2025 | 80,61 | 81,12 | 75,96 | 77,55 | -5,32% | 6,40% | 19.466.900 |
| 09/04/2025 | 76,76 | 81,99 | 76,00 | 81,91 | +3,75% | 7,80% | 22.928.300 |
| 08/04/2025 | 83,21 | 83,27 | 77,54 | 78,95 | -2,75% | 6,89% | 20.571.600 |
| 07/04/2025 | 81,01 | 83,21 | 79,30 | 81,18 | -0,36% | 4,83% | 26.582.000 |
| 04/04/2025 | 86,12 | 86,27 | 81,08 | 81,47 | -5,70% | 6,03% | 22.965.700 |
| 03/04/2025 | 88,73 | 88,90 | 86,26 | 86,39 | -0,24% | 2,98% | 12.684.100 |
| 02/04/2025 | 86,88 | 87,07 | 85,32 | 86,60 | -0,60% | 2,01% | 10.590.800 |
| 01/04/2025 | 89,75 | 89,75 | 86,61 | 87,12 | -2,94% | 3,50% | 13.922.100 |